As the VWF aptamer inhibits platelet recruitment and activation, PAI-1 levels may be reduced in thrombosis in the aptamer-treated canines, which may, in part, result in improved recanalization rates in arterial platelet-rich clots with AIS. Here, VWF is linked to androgen insensitivity syndrome.